Benefit of ICD Attenuated in CKD Patients Receiving Cardiac Resynchronization
MONDAY, Sept. 25, 2023 -- For patients with advanced chronic kidney disease (CKD) receiving cardiac resynchronization therapy (CRT), the benefit of an implantable cardioverter defibrillator (ICD) may be attenuated, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiac Resynchronization Therapy | Cardiology | Chronic Kidney Disease | Heart | Pharmaceuticals | Study | Urology & Nephrology